This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Enterotoxigenic E. Coli (ETEC) Infection
and you are
between 18 and 50
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the safety and immune response to ACE527.

Provided treatments

  • Biological: ACE527 vaccine
  • Biological: Placebo vaccine
Tris trial is registered with FDA with number: NCT00901654. The sponsor of the trial is TD Vaccines A/S and it is looking for 36 volunteers for the current phase.
Official trial title:
A Phase I, Single Center, Double-Blind, Placebo-controlled Dose Finding Clinical Study to Evaluate the Safety and Immunogenicity of the Live Attenuated, Oral Vaccine ACE527